1. Home
  2. IMRX vs VNRX Comparison

IMRX vs VNRX Comparison

Compare IMRX & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRX
  • VNRX
  • Stock Information
  • Founded
  • IMRX 2008
  • VNRX N/A
  • Country
  • IMRX United States
  • VNRX United States
  • Employees
  • IMRX N/A
  • VNRX N/A
  • Industry
  • IMRX Biotechnology: Pharmaceutical Preparations
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • IMRX Health Care
  • VNRX Health Care
  • Exchange
  • IMRX Nasdaq
  • VNRX Nasdaq
  • Market Cap
  • IMRX 62.7M
  • VNRX 58.6M
  • IPO Year
  • IMRX 2021
  • VNRX N/A
  • Fundamental
  • Price
  • IMRX $1.64
  • VNRX $0.55
  • Analyst Decision
  • IMRX Strong Buy
  • VNRX Strong Buy
  • Analyst Count
  • IMRX 3
  • VNRX 4
  • Target Price
  • IMRX $11.00
  • VNRX $4.17
  • AVG Volume (30 Days)
  • IMRX 192.2K
  • VNRX 120.5K
  • Earning Date
  • IMRX 03-20-2025
  • VNRX 05-12-2025
  • Dividend Yield
  • IMRX N/A
  • VNRX N/A
  • EPS Growth
  • IMRX N/A
  • VNRX N/A
  • EPS
  • IMRX N/A
  • VNRX N/A
  • Revenue
  • IMRX N/A
  • VNRX $1,285,827.00
  • Revenue This Year
  • IMRX N/A
  • VNRX $71,446.31
  • Revenue Next Year
  • IMRX N/A
  • VNRX N/A
  • P/E Ratio
  • IMRX N/A
  • VNRX N/A
  • Revenue Growth
  • IMRX N/A
  • VNRX 97.50
  • 52 Week Low
  • IMRX $1.00
  • VNRX $0.43
  • 52 Week High
  • IMRX $3.83
  • VNRX $1.02
  • Technical
  • Relative Strength Index (RSI)
  • IMRX 46.94
  • VNRX 46.10
  • Support Level
  • IMRX $1.60
  • VNRX $0.51
  • Resistance Level
  • IMRX $1.91
  • VNRX $0.57
  • Average True Range (ATR)
  • IMRX 0.11
  • VNRX 0.04
  • MACD
  • IMRX 0.02
  • VNRX -0.00
  • Stochastic Oscillator
  • IMRX 44.90
  • VNRX 40.00

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: